| Literature DB >> 28174010 |
Amr Hanbali1, Marwan Shaheen2, Feras Alfraih2, Wafa Al-Otaibi2, Riad El Fakih2, Tarek Owaidah2, Syed Ahmed2.
Abstract
Hypereosinophilic syndrome (HES) is a group of rare blood disorders characterized by a persistent elevation of blood eosinophil count ⩾1.5×109/L and clinical manifestations attributable to eosinophilia or tissue hypereosinophilia. Lymphocytic variant of HES (HES-L) is a known subtype according to World Health Organization classification. It is well documented in the literature that patients with HES-L are predisposed to develop T-cell lymphoma. We report a case of T-cell lymphoproliferation associated with hypereosinophilia, which has been successfully treated with mycophenolate mofetil, with resolution of skin lesions and normalization of eosinophil count and immunoglobulin E level. We believe this is a clinically relevant case since this is a rare disease with little known knowledge on its best treatment modality.Entities:
Keywords: Hypereosinophilia; Mycophenolate mofetil; T-cell lymphoproliferative disorder
Mesh:
Substances:
Year: 2017 PMID: 28174010 DOI: 10.1016/j.hemonc.2016.11.001
Source DB: PubMed Journal: Hematol Oncol Stem Cell Ther